InflaRx presented data analyses from a terminated Phase 3 study on the potential treatment for rare skin condition.

In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

InflaRx ( ($IFRX) ) has shared an announcement. On December 30, 2025, InflaRx reported detailed Phase 3 data analyses for vilobelimab in pyoderma ...

InflaRx (IFRX) outlined multiple data analyses of the Phase 3 study for vilobelimab in pyoderma gangrenosum, which was terminated earlier this ...

A 65-year-old man presented with penile drainage and foul odour 3 months after undergoing partial penectomy for the treatment of penile calciphylaxis. The patient underwent a total penectomy with ...

Monsoon weather paves the way for many worrying health concerns. The unpredictable climate also aggravates existing conditions. And with people still commuting to work and going about their day ...

Pyoderma gangrenosum lesion regression after dapsone treatment. However, after two weeks, the patient’s hematological condition deteriorated, presenting with a hemoglobin level of 7 g/dL, white blood ...

Background: Pyoderma gangrenosum (PG) is a rare dermatosis often associated with systemic diseases. There are autoinflammatory mechanisms with neutrophilic infiltrate and necrosis. Due to the high ...

From Flesh-Eating Gangrene to Glory Aged Forty for Santi Cazorla originally appeared on Athlon Sports. At 40, Santi Cazorla stunned soccer by scoring a jaw-dropping free-kick. His goal sent Real ...